A phase IIb trial of MLE-4901 in patients with vasomotor symptoms

Trial Profile

A phase IIb trial of MLE-4901 in patients with vasomotor symptoms

Planning
Phase of Trial: Phase II

Latest Information Update: 08 Apr 2017

At a glance

  • Drugs MLE 4901 (Primary)
  • Indications Hot flashes; Vasomotor symptoms
  • Focus Therapeutic Use
  • Sponsors Millendo Therapeutics
  • Most Recent Events

    • 08 Apr 2017 New trial record
    • 03 Apr 2017 According to a Millendo Therapeutics media release, this trial is expected to initiate later in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top